000 | 01113 a2200313 4500 | ||
---|---|---|---|
005 | 20250513053717.0 | ||
264 | 0 | _c19950105 | |
008 | 199501s 0 0 eng d | ||
022 | _a0271-8235 | ||
024 | 7 |
_a10.1055/s-2008-1041066 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichman, D P | |
245 | 0 | 0 |
_aMyasthenia gravis: pathogenesis and treatment. _h[electronic resource] |
260 |
_bSeminars in neurology _cJun 1994 |
||
300 |
_a106-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunization _xadverse effects |
650 | 0 | 4 |
_aMyasthenia Gravis _ximmunology |
650 | 0 | 4 |
_aNeuromuscular Junction _ximmunology |
650 | 0 | 4 |
_aReceptors, Nicotinic _ximmunology |
650 | 0 | 4 |
_aSynaptic Transmission _ximmunology |
700 | 1 | _aAgius, M A | |
773 | 0 |
_tSeminars in neurology _gvol. 14 _gno. 2 _gp. 106-10 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2008-1041066 _zAvailable from publisher's website |
999 |
_c7984154 _d7984154 |